Celgene
ABRAXANE
Manufacturer:
Celgene
Name:
ABRAXANE
HCPCS Code Descriptor:
Injection, paclitaxel protein-bound particles, 1 mg
Category:
J Code
HCPCS:
J9264
NDC(s):
68817-0134-50, 60505-6230-04
Primary Type:
Oncology
Generic Status:
Multi-Source
Route of Administration:
Intravenous
About:
ABRAXANE is an Oncology drug manufactured by Celgene and administered via the Intravenous route of administration. The J Code: J9264 is aligned to the drug ABRAXANE.